Skip to main content
Top
Published in: Annals of Hematology 11/2012

01-11-2012 | Original Article

Molecular mechanisms of a novel β-thalassaemia mutation due to the duplication of tetranucleotide ‘AGCT’ at the junction IVS-II/exon 3

Authors: Gennaro Musollino, Gabriella Mastrolonardo, Romeo Prezioso, Leonilde Pagano, Paola Primignani, Clementina Carestia, Giuseppina Lacerra

Published in: Annals of Hematology | Issue 11/2012

Login to get access

Abstract

We report a new β-thalassaemia allele detected in a young Italian woman, suffering with mild non-haemolytic anaemia (Hb < 10 g/dL) and not showing Hb variant or Heinz bodies. The allele is characterised by duplication of tetranucleotide ‘AG/CT’ (+1344/+1347) including the invariant dinucleotide ‘AG’ of IVS-II acceptor splicing site and the first two nucleotides of codon 105. β-Globin complementary DNA (cDNA) sequencing did not reveal any mutation and qualitative analysis of the reverse transcription PCR reaction showed that only the proximal 3′ splice site present in the duplicated gene is used giving race to an anomalous messenger RNA (mRNA) present in trace (1.5 %) because, most probably, rapidly degraded. In the anomalous mRNA, the insertion causes a frameshift and synthesis of an abnormal truncated β-chain (139 residues), unable to form Hb variant because of the severe conformational changes. The duplication might have arisen from secondary structures generated by quasi-palindromic sequence 5′-CCCA(C)AG/CT(CC)TGGG-3′. Restriction fragment length polymorphism analysis for the β-globin haplotype and familiar segregation analysis indicated that the mutant β-globin gene was associated with the haplotype V.
Literature
1.
go back to reference Giardine B, van Baal S, Kaimakis P et al (2007) HbVar database of human hemoglobin variants and Thalassemia mutations: 2007 update. Hum Mutat 28(2):206PubMedCrossRef Giardine B, van Baal S, Kaimakis P et al (2007) HbVar database of human hemoglobin variants and Thalassemia mutations: 2007 update. Hum Mutat 28(2):206PubMedCrossRef
2.
go back to reference Jain PK, Dozy AM, Verma IC, Chehab FF (1994) A new frameshift mutation, insertion of ATCT, at codon 48 in the beta-globin gene causes beta-thalassemia in an Indian proband. Hum Mutat 3(4):397–398PubMedCrossRef Jain PK, Dozy AM, Verma IC, Chehab FF (1994) A new frameshift mutation, insertion of ATCT, at codon 48 in the beta-globin gene causes beta-thalassemia in an Indian proband. Hum Mutat 3(4):397–398PubMedCrossRef
3.
go back to reference Frischknecht H, Kiewitz R, Schmugge M (2005) A 4 base pair TGAT insertion at codon 116 of the beta globin gene causes beta0-thalassemia. Haematologica 90(Suppl):ECR20PubMed Frischknecht H, Kiewitz R, Schmugge M (2005) A 4 base pair TGAT insertion at codon 116 of the beta globin gene causes beta0-thalassemia. Haematologica 90(Suppl):ECR20PubMed
4.
go back to reference Flatz G, Wilke K, Syagailo YV et al (1999) Beta-thalassemia in the German population: mediterranean, Asian and novel mutations. Mutations in brief no.228. Online. Hum Mutat 13(3):258PubMedCrossRef Flatz G, Wilke K, Syagailo YV et al (1999) Beta-thalassemia in the German population: mediterranean, Asian and novel mutations. Mutations in brief no.228. Online. Hum Mutat 13(3):258PubMedCrossRef
5.
go back to reference Thein SL (1992) Dominant beta thalassaemia: molecular basis and pathophysiology. Br J Haematol 80(3):273–277PubMedCrossRef Thein SL (1992) Dominant beta thalassaemia: molecular basis and pathophysiology. Br J Haematol 80(3):273–277PubMedCrossRef
6.
go back to reference Rojnuckarin P, Settapiboon R, Vanichsetaku P et al (2007) Severe beta(0) thalassemia/hemoglobin E disease caused by de novo 22-base pair duplication in the paternal allele of beta globin gene. Am J Hematol 82(7):663–665PubMedCrossRef Rojnuckarin P, Settapiboon R, Vanichsetaku P et al (2007) Severe beta(0) thalassemia/hemoglobin E disease caused by de novo 22-base pair duplication in the paternal allele of beta globin gene. Am J Hematol 82(7):663–665PubMedCrossRef
7.
go back to reference Svasti S, Boonchoy C, Vanichsetakul P, Winichagoon P, Fucharoen S (2008) Molecular mechanism of beta-thalassaemia caused by 22-bp duplication. Ann Hematol 87(8):633–637PubMedCrossRef Svasti S, Boonchoy C, Vanichsetakul P, Winichagoon P, Fucharoen S (2008) Molecular mechanism of beta-thalassaemia caused by 22-bp duplication. Ann Hematol 87(8):633–637PubMedCrossRef
8.
go back to reference Pagano L, Lacerra G, Camardella L et al (1991) Hemoglobin Neapolis, beta 126(H4)Val→Gly: a novel beta-chain variant associated with a mild beta-thalassemia phenotype and displaying anomalous stability features. Blood 78(11):3070–3075PubMed Pagano L, Lacerra G, Camardella L et al (1991) Hemoglobin Neapolis, beta 126(H4)Val→Gly: a novel beta-chain variant associated with a mild beta-thalassemia phenotype and displaying anomalous stability features. Blood 78(11):3070–3075PubMed
9.
go back to reference Lacerra G, Musollino G, Scarano C et al (2008) Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area. Gene 410(1):129–138PubMedCrossRef Lacerra G, Musollino G, Scarano C et al (2008) Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area. Gene 410(1):129–138PubMedCrossRef
10.
go back to reference Losekoot M, Fodde R, Harteveld CL et al (1990) Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia. Br J Haematol 76(2):269–274PubMedCrossRef Losekoot M, Fodde R, Harteveld CL et al (1990) Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia. Br J Haematol 76(2):269–274PubMedCrossRef
11.
go back to reference Bowden DK, Vickers MA, Higgs DR (1992) A PCR-based strategy to detect the common severe determinants of alpha thalassaemia. Br J Haematol 81(1):104–108PubMedCrossRef Bowden DK, Vickers MA, Higgs DR (1992) A PCR-based strategy to detect the common severe determinants of alpha thalassaemia. Br J Haematol 81(1):104–108PubMedCrossRef
12.
go back to reference Dode C, Krishnamoorthy R, Lamb J, Rochette J (1993) Rapid analysis of -alpha 3.7 thalassaemia and alpha alpha alpha anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 83(1):105–111PubMedCrossRef Dode C, Krishnamoorthy R, Lamb J, Rochette J (1993) Rapid analysis of -alpha 3.7 thalassaemia and alpha alpha alpha anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 83(1):105–111PubMedCrossRef
13.
go back to reference Lacerra G, Musollino G, Di Noce F et al (2007) Genotyping for known Mediterranean alpha-thalassemia point mutations using a multiplex amplification refractory mutation system. Haematologica 92(2):254–255PubMedCrossRef Lacerra G, Musollino G, Di Noce F et al (2007) Genotyping for known Mediterranean alpha-thalassemia point mutations using a multiplex amplification refractory mutation system. Haematologica 92(2):254–255PubMedCrossRef
14.
go back to reference Lacerra G, Testa R, De Angioletti M et al (2003) Hb Bronte or alpha 93(FG5)Val→Gly: a new unstable variant of the alpha 2-globin gene, associated with a mild alpha(+)-thalassemia phenotype. Hemoglobin 27(3):149–159PubMedCrossRef Lacerra G, Testa R, De Angioletti M et al (2003) Hb Bronte or alpha 93(FG5)Val→Gly: a new unstable variant of the alpha 2-globin gene, associated with a mild alpha(+)-thalassemia phenotype. Hemoglobin 27(3):149–159PubMedCrossRef
15.
go back to reference De Angioletti M, Lacerra G, Sabato V, Carestia C (2004) Beta + 45G→C: a novel silent beta-thalassaemia mutation, the first in the Kozak sequence. Br J Haematol 124(2):224–231PubMedCrossRef De Angioletti M, Lacerra G, Sabato V, Carestia C (2004) Beta + 45G→C: a novel silent beta-thalassaemia mutation, the first in the Kozak sequence. Br J Haematol 124(2):224–231PubMedCrossRef
16.
go back to reference Luukkonen B, Seraphin B (1997) The role of branchpoint-3′ splice site spacing and interaction between intron terminal nucleotides in 3′ splice site selection in Saccharomyces cerevisiae. Embo J 16(4):779–792PubMedCrossRef Luukkonen B, Seraphin B (1997) The role of branchpoint-3′ splice site spacing and interaction between intron terminal nucleotides in 3′ splice site selection in Saccharomyces cerevisiae. Embo J 16(4):779–792PubMedCrossRef
17.
go back to reference Lahr G, Brintrup J, Over S et al (2007) Codon 104(-G), a dominant beta0-thalassemia-like phenotype in a German Caucasian family is associated with mild chronic hemolytic anemia but influenced in severity by co-inherited genetic factors. Haematologica 92(9):1264–1265PubMedCrossRef Lahr G, Brintrup J, Over S et al (2007) Codon 104(-G), a dominant beta0-thalassemia-like phenotype in a German Caucasian family is associated with mild chronic hemolytic anemia but influenced in severity by co-inherited genetic factors. Haematologica 92(9):1264–1265PubMedCrossRef
18.
go back to reference Bibi A, Messaoud T, Beldjord C, Fattoum S (2006) Detection of two rare beta-thalassemia alleles found in the Tunisian population: codon 47 (+A) and codons 106/107 (+G). Hemoglobin 30(4):437–447PubMedCrossRef Bibi A, Messaoud T, Beldjord C, Fattoum S (2006) Detection of two rare beta-thalassemia alleles found in the Tunisian population: codon 47 (+A) and codons 106/107 (+G). Hemoglobin 30(4):437–447PubMedCrossRef
19.
go back to reference Hopmeier P, Krugluger W, Gu LH et al (1996) A newly discovered frameshift at codons 120–121 (+A) of the beta gene is not associated with a dominant form of beta-thalassemia. Blood 87(12):5393–5394PubMed Hopmeier P, Krugluger W, Gu LH et al (1996) A newly discovered frameshift at codons 120–121 (+A) of the beta gene is not associated with a dominant form of beta-thalassemia. Blood 87(12):5393–5394PubMed
20.
go back to reference Hall GW, Thein S (1994) Nonsense codon mutations in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation: a mechanism for the phenotype of dominant beta-thalassemia. Blood 83(8):2031–2037PubMed Hall GW, Thein S (1994) Nonsense codon mutations in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation: a mechanism for the phenotype of dominant beta-thalassemia. Blood 83(8):2031–2037PubMed
21.
Metadata
Title
Molecular mechanisms of a novel β-thalassaemia mutation due to the duplication of tetranucleotide ‘AGCT’ at the junction IVS-II/exon 3
Authors
Gennaro Musollino
Gabriella Mastrolonardo
Romeo Prezioso
Leonilde Pagano
Paola Primignani
Clementina Carestia
Giuseppina Lacerra
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 11/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1526-y

Other articles of this Issue 11/2012

Annals of Hematology 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.